Verrica Pharmaceuticals (VRCA) Operating Leases (2019 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Operating Leases of $152000.0 for Q1 2026, down 69.6% year-over-year from $500000.0 in Q1 2025, and down 37.19% quarter-over-quarter from $242000.0 in Q4 2025.
Verrica Pharmaceuticals (VRCA) Operating Leases (2019 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $152000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 69.6% year-over-year to $152000.0; the TTM figure through Mar 2026 stood at $152000.0 (down 69.6% YoY), while the FY2025 annual figure was $242000.0, down 58.49% from the prior year.
- Operating Leases for Q1 2026 stood at $152000.0, down from $242000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.4 million in Q1 2022, with the low at $152000.0 in Q1 2026.
- The 5-year median for Operating Leases is $825000.0 (2024), against an average of $816000.0.
- The sharpest annual moves came in 2022 and 2026: Operating Leases retreated 12.33% in 2022, then sank 69.6% in 2026.
- Verrica Pharmaceuticals' Operating Leases stood at $1.2 million in 2022, then retreated by 25.96% to $910000.0 in 2023, then slumped by 35.93% to $583000.0 in 2024, then plunged by 58.49% to $242000.0 in 2025, then tumbled by 37.19% to $152000.0 in 2026.
- Business Quant data shows VRCA's Operating Leases at $152000.0 in Q1 2026, $242000.0 in Q4 2025, and $330000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 416,000.00 |
| Mar 31, 2026 | 152,000.00 |
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 416,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 665,000.00 |
| Jun 30, 2024 | 744,000.00 |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | 910,000.00 |
| Sep 30, 2023 | 989,000.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.51 Mn |